Geron Corporation: Company Strategy, SWOT Analysis and 5-year Adjusted Financials

Questions: Discounts, Updates etc.

Price: $495.00

Publication Date: 11-Jun-08

Order Online Now

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Geron, a biotechnology company, specializes in developing telomerase targeted therapies for cancer and chronic degenerative diseases and human embryonic stem cell-based therapeutics. The company develops anti-cancer therapies based on telomerase inhibitors, telomerase therapeutic vaccines, and through its licensee, telomerase-based oncolytic viruses.


Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Report Highlights
    Geron's clinical portfolio includes GRN163L and GRN163L, currently being studied in Phase I/ II trials for the treatment of various cancer indications.

    Geron's revenues increased at a CAGR of 27% during 2002-2006, from $1 million to $3 million. This increase was mainly due to the increase in royalties, license fees, contract and collaborative revenues along with royalties from the product sales of telomerase detection and telomere measurement kits.

    Geron's revenues are forecast to grow at a CAGR of 54% from $3 million in 2006 to $18 million in 2010, mainly due to the expected increase in milestone payments from Merck.


    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    Other users found this report page using the following search terms: swot analysis geron stem cell corporation biomed engineering tissue company

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.